Physician profile
Ami Ben-Artzi
NPI 1568505170
$68,195.44
in general payments reported to CMS, 2019-2025
51 companies · $3,443 in 2025
The $3,443 reported for 2025 was more than what 80% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $5,789 · 2021: $2,726 · 2022: $2,518 · 2023: $2,689 · 2024: $11K · 2025: $3,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,172 · Consulting Fee: $6,900 · Travel and Lodging: $1,144 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,172.11 |
| Consulting Fee | $6,900.00 |
| Travel and Lodging | $1,144.21 |
| Education | $230.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $26,061.15 | 2019 | |
| Ucb, INC. | $9,267.28 | 2019-2025 | Bimzelx, Cimzia |
| Amgen INC. | $8,019.45 | 2019-2025 | Evenity, Enbrel, Otezla |
| Celgene Corporation | $6,681.87 | 2019 | |
| Abbvie INC. | $2,352.40 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Janssen Biotech, INC. | $2,150.71 | 2019-2025 | Tremfya, Simponi Aria, Remicade |
| Butterfly Network, INC. | $1,999.00 | 2019 | |
| Horizon Therapeutics Plc | $1,522.11 | 2019-2023 | Krystexxa |
| Gilead Sciences, INC. | $1,412.38 | 2019-2024 | |
| Glaxosmithkline, LLC. | $1,208.54 | 2019-2025 | Benlysta |
| Lilly USA, LLC | $1,096.59 | 2019-2025 | Taltz, Olumiant, Zepbound |
| Mallinckrodt Hospital Products INC. | $960.40 | 2020-2025 | Acthar |
| Esaote North America, INC. | $885.41 | 2021 | |
| Pfizer INC. | $699.32 | 2019-2025 | |
| Genzyme Corporation | $513.51 | 2019-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $459.62 | 2022-2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $373.91 | 2019-2025 | |
| Radius Health, INC. | $262.75 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $176.72 | 2021-2025 | Saphnelo |
| Sobi, INC | $174.87 | 2019-2025 | |
| Fresenius Kabi USA, LLC | $164.53 | 2023-2025 | Idacio |
| Aurinia Pharma U.S., INC. | $163.98 | 2022-2024 | Lupkynis |
| Genentech USA, INC. | $159.89 | 2023-2024 | Xolair, Actemra |
| Depuy Synthes Sales INC. | $155.69 | 2019-2023 | Orthovisc |
| Alexion Pharmaceuticals, INC. | $137.51 | 2024-2025 | Strensiq |
| Sanofi-Aventis U.S. LLC | $121.53 | 2019-2024 | |
| Janssen Scientific Affairs, LLC | $119.80 | 2021 | |
| Octapharma USA, INC. | $82.80 | 2023-2024 | Octagam Immune Globulin (Human) |
| Kyowa Kirin, INC. | $65.75 | 2023-2025 | |
| Currax Pharmaceuticals LLC | $65.44 | 2022-2024 | Contrave |
| Pacira Therapeutics, INC. | $63.70 | 2019-2020 | |
| Fidia Pharma USA INC. | $59.48 | 2022-2024 | Hymovis |
| Pacira Pharmaceuticals Incorporated | $58.19 | 2022-2023 | Exparel, Zilretta, Iovera |
| Azurity Pharmaceuticals, INC. | $47.31 | 2023-2025 | Horizant, Horizant |
| Bioventus LLC | $46.94 | 2019-2022 | |
| Averitas Pharma INC. | $44.82 | 2023 | Qutenza |
| Biogen, INC. | $44.12 | 2024 | Tofidence |
| Antares Pharma, INC. | $34.72 | 2019-2020 | |
| Csl Behring | $28.82 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.69 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $25.51 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.25 | 2023 | Orencia |
| Grifols USA, LLC | $23.00 | 2024 | Gamunex-C |
| Medexus Pharma, INC. | $22.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.80 | 2023 | Gattex |
| Ultragenyx Pharmaceutical INC. | $21.12 | 2021 | |
| Novo Nordisk INC | $19.49 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $19.36 | 2023 | Arcalyst |
| Avanos Medical | $17.40 | 2023 | Trivisc Sodium Hyaluronate |
| Teleflex LLC | $15.13 | 2023 | Titan Sgs Standard Gastric Stapler |
| Sonex Health, INC. | $13.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Ben-Artzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.